Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
16.21
-0.07 (-0.43%)
At close: Jun 18, 2026, 4:00 PM EDT
16.30
+0.09 (0.56%)
After-hours: Jun 18, 2026, 7:43 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,700 employees as of December 31, 2025. The number of employees increased by 400 or 4.82% compared to the previous year.
Employees
8,700
Change (1Y)
400
Growth (1Y)
4.82%
Revenue / Employee
$350,099
Profits / Employee
$14,037
Market Cap
5.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8,700 | 400 | 4.82% |
| Dec 31, 2024 | 8,300 | 450 | 5.73% |
| Dec 31, 2023 | 7,850 | 250 | 3.29% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
AMRX News
- 1 day ago - Amneal Pharmaceuticals Proxy statement: Proxy filing - Filings
- 2 days ago - The Healthcare M&A Wave - Forbes
- 9 days ago - Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals - PRNewsWire
- 10 days ago - Amneal Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 14 days ago - Amneal Pharmaceuticals announces interim results from ELEVATE-PD study - TheFly
- 14 days ago - Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease - GlobeNewsWire
- 15 days ago - Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution - TheFly
- 15 days ago - Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution - TheFly